New weapon against tough cancers enters first human tests
Disease control
Recruiting now
This is the first study in people to test a new drug called XMT-1660 for several types of advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see what side effects it causes. Researchers will also look for early signs that the drug can s…
Phase: PHASE1 • Sponsor: Mersana Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC